| Trial ID: | L3650 |
| Source ID: | NCT04528212
|
| Associated Drug: |
Glimepiride Tablets
|
| Title: |
Fenofibrate Versus Curcumin in Type 2 Diabetic Patients
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Glimepiride Tablets|DRUG: glimepiride plus fenofibrate|DRUG: glimepiride plus curcumin
|
| Outcome Measures: |
Primary: fetuin-A (mg/L), human Fetuin A protein, three months|Sirtuin1 (SIRT1) (ng/ml), human Sirtuin1 a Protein - Recombinant human SIRT1 protein, three months | Secondary: Total Cholesterol (mg/dl), Total Cholesterol, Three Months|Triglyceride (mg/dl), Triglyceride, Three Months
|
| Sponsor/Collaborators: |
Sponsor: Rehab Werida
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
60
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2020-11-01
|
| Completion Date: |
2021-12-01
|
| Results First Posted: |
|
| Last Update Posted: |
2022-03-04
|
| Locations: |
Tanta University Hospital, Tanta, El-Gharbia, 31527, Egypt
|
| URL: |
https://clinicaltrials.gov/show/NCT04528212
|
